Xeris Biopharma Holdings, Inc. XERS Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $111.04M+55.0% | $71.62M+6.2% | $67.45M-44.7% | $121.97M+81.3% | ||
| $204.18M+26.5% | $161.41M+10.4% | $146.25M+36.1% | $107.49M+195% | ||
| $68.67M+42.5% | $48.18M+24.0% | $38.84M+57.0% | $24.74M+36.5% | ||
| $240.31M+43.3% | $167.66M+7.3% | $156.26M-16.4% | $186.82M+31.0% | ||
| $4.95M-11.1% | $5.56M-6.8% | $5.97M+8.2% | $5.52M-16.8% | ||
| $22.86M0.0% | $22.86M0.0% | $22.86M0.0% | $22.86M0.0% | ||
| $88.08M-11.0% | $98.92M-9.9% | $109.76M-9.0% | $120.61M-8.2% | ||
| $383.53M+18.7% | $323.06M+0.1% | $322.6M-6.4% | $344.52M+13.2% | ||
| $3.08M+34.3% | $2.29M-80.2% | $11.57M+151% | $4.61M-48.4% | ||
| $109.57M+9.1% | $100.44M+5.5% | $95.19M+29.3% | $73.62M-6.9% | ||
| $220.34M+1.5% | $217.01M+13.7% | $190.93M+2.1% | $187.08M+112% | ||
| $369.84M+4.9% | $352.68M+7.1% | $329.38M+10.0% | $299.34M+43.1% | ||
| $17K+13.3% | $15K+7.1% | $14K0.0% | $14K+7.7% | ||
| -$671.31M+0.1% | -$671.86M-8.9% | -$617.03M-11.2% | -$554.77M-20.6% | ||
| $13.69M+146% | -$29.62M-337% | -$6.78M-115% | $45.19M-52.6% | ||
| $383.53M+18.7% | $323.06M+0.1% | $322.6M-6.4% | $344.52M+13.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Xeris Biopharma Holdings, Inc.'s total assets?
- Xeris Biopharma Holdings, Inc. (XERS) holds $392.0M in total assets, up 24.3% year over year.
- How much debt does Xeris Biopharma Holdings, Inc. have?
- Xeris Biopharma Holdings, Inc. carries $258.6M in total debt against $13.0M of shareholders' equity, a debt-to-equity ratio of 19.87.
- How much cash does Xeris Biopharma Holdings, Inc. have?
- Xeris Biopharma Holdings, Inc. holds $111.8M in cash and equivalents.
- Can Xeris Biopharma Holdings, Inc. cover its short-term obligations?
- Its current ratio is 2.12 — current assets exceed current liabilities.
- Where does Xeris Biopharma Holdings, Inc.'s balance sheet data come from?
- Every line is extracted from Xeris Biopharma Holdings, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
